Data Foundry

Drug recalls 2016

20 mcg/mL HYDROmorphone HCl and 0 — Class II drug recall D-1409-2016

Terminated recall by Pharmedium Services, LLC, reported 2016-07-27, distributed nationwide. Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable

Recall numberD-1409-2016
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmPharmedium Services, LLC, Lake Forest, IL, United States
Recall initiated2016-05-05
Classified2016-07-16
Reported by FDA2016-07-27
Terminated2018-03-06
DistributedNationwide (US)
Quantity435 monoject
Reason classesforeign material, sterility, specification failure
NDC61553-0620-12
Lot numbers160420116M, 160540135M, 160630121M, 160730218M, 160760126M, 160770152M, 160810169M, 160840206M, 160900133M, 160940210M
Expiration dates2016-05-06, 2016-05-12, 2016-05-24, 2016-06-02, 2016-06-12, 2016-06-14, 2016-06-16, 2016-06-20, 2016-06-23, 2016-07-03

Product

20 mcg/mL HYDROmorphone HCl and 0.06% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride; 55 mL in 60 mL Monoject Syringe, Service Code 2T6620, Rx Only, Compounded by PharMEDium Services, LLC, Memphis, TN 36141, NDC 61553-620-12

Reason for recall

Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1409-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.